Table 1.
Compd. | X | n | R2 | R1 | IC50 (μM) a | |||
---|---|---|---|---|---|---|---|---|
HT-29 | H-460 | A-549 | MDA-MB-231 | |||||
5a | O | 2 | 2-Cl, 6-CH3 | 0.15 ± 0.14 | 0.089 ± 0.11 | 0.36 ± 0.27 | 0.75 ± 0.65 | |
5b | O | 2 | 3,4-(CH3)2 | 1.09 ± 0.21 | 1.50 ± 0.13 | 2.33 ± 1.52 | 2.42 ± 0.28 | |
5c | O | 3 | 2-Cl, 6-CH3 | 0.36 ± 0.72 | 0.27 ± 0.12 | 0.82 ± 0.43 | 1.08 ± 0.15 | |
5d | O | 3 | 3,4-(CH3)2 | 1.72 ± 0.37 | 2.93 ± 0.62 | 5.46 ± 0.38 | 3.92 ± 1.24 | |
5e | O | 3 | 4-F | 2.64 ± 0.53 | 1.19 ± 0.96 | 3.41 ± 1.27 | 2.72 ± 0.42 | |
5f | S | 2 | 4-Cl | 0.24 ± 0.17 | 0.77 ± 0.22 | 2.30 ± 0.18 | 2.59 ± 0.36 | |
5g | S | 2 | 4-OCF3 | 1.05 ± 0.012 | 1.28 ± 0.68 | 2.81 ± 0.73 | 3.02 ± 0.51 | |
5h | S | 3 | 4-Cl | 0.65 ± 0.33 | 1.02 ± 0.74 | 1.44 ± 0.39 | 3.13 ± 0.85 | |
5i | S | 3 | 4-OCF3 | 2.41 ± 0.21 | 2.58 ± 0.74 | 4.86 ± 0.56 | 4.07 ± 1.02 | |
Sorafenib | 3.27 ± 0.32 | 2.15 ± 0.43 | 4.47± 0.28 | 3.81± 0.50 |
a Results are expressed as means ± SD (standard deviation) of three independent experiments.